Figures & data
FIG. 1 Viability of bifidobacteria in feces after the oral administration of protected bifidobacteria-loaded alginate poly-l-lysine microparticles in healthy human volunteers. * Significantly different from unprotected bifidobacteria cultures.
![FIG. 1 Viability of bifidobacteria in feces after the oral administration of protected bifidobacteria-loaded alginate poly-l-lysine microparticles in healthy human volunteers. * Significantly different from unprotected bifidobacteria cultures.](/cms/asset/abd049b9-cedb-45f1-b525-9626d5351d4d/idrd_a_206716_uf0001_b.gif)
FIG. 2 Viability of lactic acid bacteria in feces after the oral administration of protected bifidobacteria-loaded alginate poly-l-lysine microparticles in healthy human volunteers.
![FIG. 2 Viability of lactic acid bacteria in feces after the oral administration of protected bifidobacteria-loaded alginate poly-l-lysine microparticles in healthy human volunteers.](/cms/asset/b685a64e-2255-4af0-872e-2bb09e9c3c38/idrd_a_206716_uf0002_b.gif)
FIG. 3 Viability of enterobacteriaceae in feces after the oral administration of protected bifidobacteria-loaded alginate poly-l-lysine microparticles in healthy human volunteers.
![FIG. 3 Viability of enterobacteriaceae in feces after the oral administration of protected bifidobacteria-loaded alginate poly-l-lysine microparticles in healthy human volunteers.](/cms/asset/070c9a8e-ff70-410f-b08d-27adbd3f4e3c/idrd_a_206716_uf0003_b.gif)
FIG. 4 Viability of staphylococci in feces after the oral administration of protected bifidobacteria-loaded alginate poly-l-lysine microparticles in healthy human volunteers.
![FIG. 4 Viability of staphylococci in feces after the oral administration of protected bifidobacteria-loaded alginate poly-l-lysine microparticles in healthy human volunteers.](/cms/asset/b74faca6-a80b-47cd-9942-d1b47275706f/idrd_a_206716_uf0004_b.gif)
TABLE 1 Intervals between bowel movements (days) after the oral administration of unprotected bifidobacteria cultures (group A) and protected bifidobacteria-loaded alginate poly-l-lysine microparticles (group B) to healthy human volunteers
TABLE 2 Number of volunteers by scoring indices of fecal volume after the oral administration of unprotected bifidobacteria cultures (group A) and protected bifidobacteria-loaded alginate poly-l-lysine microparticles (group B)
TABLE 3 Number of volunteers by scoring indices of fecal viscosity after the oral administration of unprotected bifidobacteria cultures (group A) and protected bifidobacteria-loaded alginate poly-l-lysine microparticles (group B)